Literature DB >> 17521486

Reliable change on the Dementia Rating Scale.

Otto Pedraza1, Glenn E Smith, Robert J Ivnik, Floyd B Willis, Tanis J Ferman, Ronald C Petersen, Neill R Graff-Radford, John A Lucas.   

Abstract

A central role for neuropsychological evaluations is the measurement of change in cognitive functioning over time. However, change scores obtained from repeated neuropsychological assessments may be affected by normal variability because of measurement error and practice effects caused by repeated measurements. The current study uses reliable change estimates to establish normative rates of change on the Dementia Rating Scale from baseline to first follow-up testing among 1080 cognitively normal adults aged 65 and older. Results showed that a 6-point decline by European Americans or a 9-point decline by African American adults within a 9-15 month test-retest interval represents reliable change. Within a 16-24-month test-retest interval, a 7-point decline among European Americans or an 8-point decline among African American adults represents reliable change. In addition, preliminary cross-validation was performed in a clinical comparison sample of another 22 older adults. The findings are discussed in the context of potential clinical and research applications.

Entities:  

Mesh:

Year:  2007        PMID: 17521486     DOI: 10.1017/S1355617707070920

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  10 in total

1.  Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.

Authors:  Jonathan Graff-Radford; Bradley F Boeve; Otto Pedraza; Tanis J Ferman; Scott Przybelski; Timothy G Lesnick; Prashanthi Vemuri; Matthew L Senjem; Glenn E Smith; David S Knopman; Val Lowe; Clifford R Jack; Ronald C Petersen; Kejal Kantarci
Journal:  Brain       Date:  2012-07-18       Impact factor: 13.501

2.  Specific measures of executive function predict cognitive decline in older adults.

Authors:  Lindsay R Clark; Dawn M Schiehser; Gali H Weissberger; David P Salmon; Dean C Delis; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

3.  Robust and expanded norms for the Dementia Rating Scale.

Authors:  Otto Pedraza; John A Lucas; Glenn E Smith; Ronald C Petersen; Neill R Graff-Radford; Robert J Ivnik
Journal:  Arch Clin Neuropsychol       Date:  2010-04-28       Impact factor: 2.813

4.  Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism.

Authors:  Nobuko Kemmotsu; Catherine C Price; Genko Oyama; Michael S Okun; Kelly D Foote; Laura L S Howe; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2011-01       Impact factor: 3.535

5.  Reliable change in neuropsychological assessment of breast cancer survivors.

Authors:  Charissa Andreotti; James C Root; Sanne B Schagen; Brenna C McDonald; Andrew J Saykin; Thomas M Atkinson; Yuelin Li; Tim A Ahles
Journal:  Psychooncology       Date:  2015-03-23       Impact factor: 3.894

6.  Fibrillar amyloid correlates of preclinical cognitive decline.

Authors:  Cynthia M Stonnington; Kewei Chen; Wendy Lee; Dona E C Locke; Amylou C Dueck; Xiaofen Liu; Auttawut Roontiva; Adam S Fleisher; Richard J Caselli; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2013-04-11       Impact factor: 21.566

7.  Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology.

Authors:  Mark W Bondi; Glenn E Smith
Journal:  J Int Neuropsychol Soc       Date:  2014-02-04       Impact factor: 2.892

8.  Faulty Adaptation to Repeated Face-Name Associative Pairs in Mild Cognitive Impairment is Predictive of Cognitive Decline.

Authors:  Sarah M Jurick; Gali H Weissberger; Lindsay R Clark; Christina E Wierenga; Yu-Ling Chang; Dawn M Schiehser; S Duke Han; Amy J Jak; Sheena I Dev; Mark W Bondi
Journal:  Arch Clin Neuropsychol       Date:  2018-03-01       Impact factor: 2.813

Review 9.  Assessing individual-level change in dementia research: a review of methodologies.

Authors:  Aja Louise Murray; Marlena Vollmer; Ian J Deary; Graciela Muniz-Terrera; Tom Booth
Journal:  Alzheimers Res Ther       Date:  2021-01-15       Impact factor: 6.982

10.  Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial.

Authors:  Erin L Abner; Brandon C Dennis; Melissa J Mathews; Marta S Mendiondo; Allison Caban-Holt; Richard J Kryscio; Frederick A Schmitt; John J Crowley
Journal:  Trials       Date:  2012-11-20       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.